Texas Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 61 (85% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 19,405
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 78.84%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 1,666
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 72.39%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 18.88% 24.91%
White, Hispanic/Latino Patients 50.11% 49.88%
Black/African American, Non-Hispanic/Latino Patients 13.08% 7.14%
Black/African American, Hispanic/Latino Patients 0.58% 0.72%
Asian Patients3 1.10% 0.54%
American Indian/Alaska Native Patients3 0.37% 0.24%
Native Hawaiian/Other Pacific Islander Patients3 0.22% 0.78%
Patients with More than one race3 1.92% 2.22%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.98% 3.78%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.79% 0.84%
Unreported/Refused to Report Race and Ethnicity 9.96% 8.94%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 2,943
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 87.17%
COVID-19 Immunization Series Completed 4,283
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 86.63%
COVID-19 Immunization Series Additional 999
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 76.88%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 11.86% 12.51% 20.92%
White, Hispanic/Latino Patients 57.19% 57.67% 53.05%
Black/African American, Non-Hispanic/Latino Patients 10.02% 8.48% 8.01%
Black/African American, Hispanic/Latino Patients 0.75% 0.44% 0.10%
Asian Patients3 1.09% 1.61% 1.20%
American Indian/Alaska Native Patients3 0.27% 0.40% 2.30%
Native Hawaiian/Other Pacific Islander Patients3 0.34% 0.28% 0.20%
Patients with More than one race3 1.26% 3.08% 1.30%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 9.65% 9.11% 3.40%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.41% 0.75% 1.20%
Unreported/Refused to Report Race and Ethnicity 7.17% 5.67% 8.31%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 27.87%
1 to 24 Hours 29.51%
More Than 24 Hours 42.62%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 6.56%
Staffing to administer the vaccine 26.23%
Vaccine confidence 42.62%
Vaccine storage capacity 1.64%
Vaccine supply 3.28%
Other 6.56%
None 31.15%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 26.23%
Average Percent of Health Center Visits Conducted Virtually 19.34%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 36.07%
Number of Mobile Van Sites 15
Number of Pop-up Clinics 22
Number of School-Based Vaccination Sites 14

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 1.64%
Refer patients to another organization that provides monoclonal antibody therapies 65.57%
None 32.79%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 3.28%
Patient awareness/education 1.64%
Staffing capacity 14.75%
Therapy administration/onsite logistics 22.95%
Other 4.92%
None 67.21%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021